97927-95-2 Usage
General Description
Ethanone, 1-[2-(methylamino)phenyl]-2-(1-methyl-1H-tetrazol-5-yl)- is a chemical compound that contains a ketone group attached to a phenyl ring with a methylamino substituent and a tetrazol-5-yl group. Ethanone, 1-[2-(methylamino)phenyl]-2-(1-methyl-1H-tetrazol-5-yl)- has potential applications in medicinal chemistry and pharmaceutical research due to its unique structure and potential biological activity. The presence of the methylamino and tetrazol-5-yl groups may confer specific molecular properties that could be beneficial for drug development or other applications in the field of chemistry. Further research is likely needed to fully understand the properties and potential uses of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 97927-95-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,9,2 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 97927-95:
(7*9)+(6*7)+(5*9)+(4*2)+(3*7)+(2*9)+(1*5)=202
202 % 10 = 2
So 97927-95-2 is a valid CAS Registry Number.
97927-95-2Relevant articles and documents
Antihypertensive 3-tetrazoyl-4-quinolones
-
, (2008/06/13)
Novel quinolones of formula I STR1 and pharmaceutically acceptable acid addition salts thereof in which the dotted line between positions 2 and 3 of the quinolone ring represents an optional bond, R is hydrogen, 1-methyl or 2-lower alkyl; R1 is lower alkyl; R2 is hydrogen, halo, lower alkyl, lower alkoxy, trifluoromethyl, cyano, difluoromethoxy, methylsulphinyl, phenylsulphinyl or the group --NR4 R5 or the N-oxide thereof wherein R4 and R5, which may be the same or different, are lower alkyl or, together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino or morpholino radical; and R3 is hydrogen, fluoro, lower alkyl or lower alkoxy provided that, when R3 is lower alkoxy, R2 is other than lower alkoxy have utility as antihypertensive agents. Processes for preparing the quinolones and pharmaceutical compositions containing them are disclosed.